http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 07 Jul 2026 05:21:09 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+Comments/Larimar+Therapeutics+%28LRMR%29+Reiterated+at+Market+Outperform+by+Citizens+/26737599.html <p>Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ: LRMR).</p><p>The analyst commented, "This Thursday (July 9) at 10 a.m. ET, we will host FARA CEO Jennifer Farmer to discuss recent developments in the Friedreich’s Ataxia (FA) pipeline on the heels of updated data from Larimar Therapeutic’s ongoing open-label trial of nomlabofusp; we reiterate our Market Outperform rating and $18 risk-adjusted, DCF-derived price target. Ms. Farmer will be able to provide additional context on nomlabofusp’s perceived benefit/risk profile from the patient community perspective. Additionally, we plan to discuss real world feedback on Skyclarys’ http://www.streetinsider.com/Analyst+Comments/Larimar+Therapeutics+%28LRMR%29+Reiterated+at+Market+Outperform+by+Citizens+/26737599.html Tue, 07 Jul 2026 05:21:09 -0400 GSGN LRMR LXEO SLDB http://www.streetinsider.com/Analyst+Comments/Larimar+Therapeutics+%28LRMR%29+Reiterated+at+Market+Outperform+by+Citizens+/26737599.html <p>Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ: LRMR).</p><p>The analyst commented, "This Thursday (July 9) at 10 a.m. ET, we will host FARA CEO Jennifer Farmer to discuss recent developments in the Friedreich’s Ataxia (FA) pipeline on the heels of updated data from Larimar Therapeutic’s ongoing open-label trial of nomlabofusp; we reiterate our Market Outperform rating and $18 risk-adjusted, DCF-derived price target. Ms. Farmer will be able to provide additional context on nomlabofusp’s perceived benefit/risk profile from the patient community perspective. Additionally, we plan to discuss real world feedback on Skyclarys’ http://www.streetinsider.com/Analyst+Comments/Larimar+Therapeutics+%28LRMR%29+Reiterated+at+Market+Outperform+by+Citizens+/26737599.html Tue, 07 Jul 2026 05:21:09 -0400 GSGN LRMR LXEO SLDB http://www.streetinsider.com/Analyst+Comments/Larimar+Therapeutics+%28LRMR%29+Reiterated+at+Market+Outperform+by+Citizens+/26737599.html <p>Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ: LRMR).</p><p>The analyst commented, "This Thursday (July 9) at 10 a.m. ET, we will host FARA CEO Jennifer Farmer to discuss recent developments in the Friedreich’s Ataxia (FA) pipeline on the heels of updated data from Larimar Therapeutic’s ongoing open-label trial of nomlabofusp; we reiterate our Market Outperform rating and $18 risk-adjusted, DCF-derived price target. Ms. Farmer will be able to provide additional context on nomlabofusp’s perceived benefit/risk profile from the patient community perspective. Additionally, we plan to discuss real world feedback on Skyclarys’ http://www.streetinsider.com/Analyst+Comments/Larimar+Therapeutics+%28LRMR%29+Reiterated+at+Market+Outperform+by+Citizens+/26737599.html Tue, 07 Jul 2026 05:21:09 -0400 GSGN LRMR LXEO SLDB http://www.streetinsider.com/Analyst+Comments/Larimar+Therapeutics+%28LRMR%29+Reiterated+at+Market+Outperform+by+Citizens+/26737599.html <p>Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ: LRMR).</p><p>The analyst commented, "This Thursday (July 9) at 10 a.m. ET, we will host FARA CEO Jennifer Farmer to discuss recent developments in the Friedreich’s Ataxia (FA) pipeline on the heels of updated data from Larimar Therapeutic’s ongoing open-label trial of nomlabofusp; we reiterate our Market Outperform rating and $18 risk-adjusted, DCF-derived price target. Ms. Farmer will be able to provide additional context on nomlabofusp’s perceived benefit/risk profile from the patient community perspective. Additionally, we plan to discuss real world feedback on Skyclarys’ http://www.streetinsider.com/Analyst+Comments/Larimar+Therapeutics+%28LRMR%29+Reiterated+at+Market+Outperform+by+Citizens+/26737599.html Tue, 07 Jul 2026 05:21:09 -0400 GSGN LRMR LXEO SLDB http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Tamayo+Louis+Edward/26722493.html si-local-file:///var/storage/secattach/20260701/26722493.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Tamayo+Louis+Edward/26722493.html Wed, 01 Jul 2026 18:50:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Tamayo+Louis+Edward/26722493.html si-local-file:///var/storage/secattach/20260701/26722493.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Tamayo+Louis+Edward/26722493.html Wed, 01 Jul 2026 18:50:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Otero+Jose+Manuel/26722490.html si-local-file:///var/storage/secattach/20260701/26722490.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Otero+Jose+Manuel/26722490.html Wed, 01 Jul 2026 18:49:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Otero+Jose+Manuel/26722490.html si-local-file:///var/storage/secattach/20260701/26722490.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Otero+Jose+Manuel/26722490.html Wed, 01 Jul 2026 18:49:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Bhalla+Narinder+Pal/26722486.html si-local-file:///var/storage/secattach/20260701/26722486.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Bhalla+Narinder+Pal/26722486.html Wed, 01 Jul 2026 18:48:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Bhalla+Narinder+Pal/26722486.html si-local-file:///var/storage/secattach/20260701/26722486.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Bhalla+Narinder+Pal/26722486.html Wed, 01 Jul 2026 18:48:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Townsend+Richard+Nolan/26722484.html si-local-file:///var/storage/secattach/20260701/26722484.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Townsend+Richard+Nolan/26722484.html Wed, 01 Jul 2026 18:47:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Townsend+Richard+Nolan/26722484.html si-local-file:///var/storage/secattach/20260701/26722484.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+29++Filed+by%3A+Townsend+Richard+Nolan/26722484.html Wed, 01 Jul 2026 18:47:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Otero+Jose+Manuel/26721755.html si-local-file:///var/storage/secattach/20260701/26721755.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Otero+Jose+Manuel/26721755.html Wed, 01 Jul 2026 16:54:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Otero+Jose+Manuel/26721755.html si-local-file:///var/storage/secattach/20260701/26721755.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Otero+Jose+Manuel/26721755.html Wed, 01 Jul 2026 16:54:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Tamayo+Louis+Edward/26721575.html si-local-file:///var/storage/secattach/20260701/26721575.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Tamayo+Louis+Edward/26721575.html Wed, 01 Jul 2026 16:44:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Tamayo+Louis+Edward/26721575.html si-local-file:///var/storage/secattach/20260701/26721575.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Tamayo+Louis+Edward/26721575.html Wed, 01 Jul 2026 16:44:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Bhalla+Narinder+Pal/26721574.html si-local-file:///var/storage/secattach/20260701/26721574.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Bhalla+Narinder+Pal/26721574.html Wed, 01 Jul 2026 16:43:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Bhalla+Narinder+Pal/26721574.html si-local-file:///var/storage/secattach/20260701/26721574.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Bhalla+Narinder+Pal/26721574.html Wed, 01 Jul 2026 16:43:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Townsend+Richard+Nolan/26721550.html si-local-file:///var/storage/secattach/20260701/26721550.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Townsend+Richard+Nolan/26721550.html Wed, 01 Jul 2026 16:42:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Townsend+Richard+Nolan/26721550.html si-local-file:///var/storage/secattach/20260701/26721550.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Lexeo+Therapeutics%2C+Inc.+++++++++++++++Filed+by%3A+Townsend+Richard+Nolan/26721550.html Wed, 01 Jul 2026 16:42:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+25/26707495.html si-local-file:///var/storage/secattach/20260629/26707495.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+25/26707495.html Mon, 29 Jun 2026 17:06:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+25/26707495.html si-local-file:///var/storage/secattach/20260629/26707495.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+25/26707495.html Mon, 29 Jun 2026 17:06:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+25++Filed+by%3A+Altschuler+Steven/26707195.html si-local-file:///var/storage/secattach/20260629/26707195.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+25++Filed+by%3A+Altschuler+Steven/26707195.html Mon, 29 Jun 2026 16:46:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+25++Filed+by%3A+Altschuler+Steven/26707195.html si-local-file:///var/storage/secattach/20260629/26707195.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+25++Filed+by%3A+Altschuler+Steven/26707195.html Mon, 29 Jun 2026 16:46:00 -0400 LXEO O.60706989 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+25++Filed+by%3A+Agger+Mette+Kirstine/26707185.html si-local-file:///var/storage/secattach/20260629/26707185.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lexeo+Therapeutics%2C+Inc.++For%3A+Jun+25++Filed+by%3A+Agger+Mette+Kirstine/26707185.html Mon, 29 Jun 2026 16:45:00 -0400 LXEO O.60706989